Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy-Reference-Cited by-同舟云学术

Rapid diagnostics and ceftazidime/avibactam for KPC-producing Klebsiella pneumoniae bloodstream infections: impact on mortality and role of combination therapy

Published:2023-02-20 Issue:4 Volume:42 Page:431-439
ISSN:0934-9723
Container-title:European Journal of Clinical Microbiology & Infectious Diseases
language:en
Short-container-title:Eur J Clin Microbiol Infect Dis

Author:

Boattini Matteo^ORCID,Bianco Gabriele,Charrier Lorena,Comini Sara,Iannaccone Marco,Almeida André,Cavallo Rossana,De Rosa Francesco Giuseppe,Costa Cristina

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s10096-023-04577-x.pdf

Reference32 articles.

1. Albiger B, Glasner C, Struelens MJ, Grundmann H, Monnet DL, European survey of carbapenemase-producing enterobacteriaceae (EuSCAPE) working group (2015) Carbapenemase-producing Enterobacteriaceae in Europe: assessment by national experts from 38 countries, May 2015. Euro Surveill 20 pii=30062

2. Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M et al (2013) Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis 13:785–796

3. Tzouvelekis LS, Markogiannakis A, Piperaki E, Souli M, Daikos GL (2014) Treating infections caused by carbapenemase-producing enterobacteriaceae. Clin Microbiol Infect 20:862–872

4. Iacchini S, Sabbatucci M, Gagliotti C, Rossolini GM, Moro ML, Iannazzo S et al (2019) Bloodstream infections due to carbapenemase-producing enterobacteriaceae in Italy: results from nationwide surveillance, 2014 to 2017. Euro Surveill 24:1800159. https://doi.org/10.2807/1560-7917.ES.2019.24.5.1800159

5. Boattini M, Bianco G, Iannaccone M, Ghibaudo D, Almeida A, Cavallo R et al (2021) Fast-track identification of CTX-M-extended-spectrum-β-lactamase- and carbapenemase-producing Enterobacterales in bloodstream infections: implications on the likelihood of deduction of antibiotic susceptibility in emergency and internal medicine departments. Eur J Clin Microbiol Infect Dis 40:1495–1501. https://doi.org/10.1007/s10096-021-04192-8

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Complete Genome Sequence of a Klebsiella pneumoniae Strain Carrying Novel Variant blaKPC-203, Cross-Resistant to Ceftazidime/Avibactam and Cefiderocol, but Susceptible to Carbapenems, Isolated in Italy, 2023;Pathogens;2024-06-15

2. Ceftazidime-avibactam combination therapy versus monotherapy for treating carbapenem-resistant gram-negative infection: a systemic review and meta-analysis;Infection;2024-05-13

3. Proteome analysis, genetic characterization, and antibiotic resistance patterns of Klebsiella pneumoniae clinical isolates;AMB Express;2024-05-09

4. Bloodstream Infections by Pantoea Species: Clinical and Microbiological Findings from a Retrospective Study, Italy, 2018–2023;Antibiotics;2023-12-13

5. Prevalence and mortality of ceftazidime/avibactam-resistant KPC-producing Klebsiella pneumoniae bloodstream infections (2018–2022);European Journal of Clinical Microbiology & Infectious Diseases;2023-11-21